Future Fertility

News

It's no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents.

News

AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.